Mushrooms: Nature's Antibiotics?

Mushrooms have been used for medicinal purposes throughout history, and in modern times, several antibiotics have been isolated from various mushrooms and microfungi, including penicillin and griseofulvin. Research has shown that wild mushroom extracts can potentiate the action of standard antibiotics against multi-resistant bacteria. Certain mushrooms have also been found to have antimicrobial properties, and their extracts have been used to create antibiotic nanoparticles.

Mushrooms have been used for medicine throughout history

Mushrooms, the fruiting body of a macrofungus, have been used throughout history for medicinal purposes. The use of mushrooms as medicine dates back thousands of years, with ancient civilisations utilising their antimicrobial properties for wound healing and infection treatment.

For example, Ötzi, the Ice Man, who lived nearly 5300 years ago, carried amadou and a birch polypore in a pouch to help him survive in the Alps of northern Italy. The ancient Greeks also recognised the medicinal value of mushrooms, with the physician Hippocrates classifying the amadou mushroom (Fomes fomentarius) as a potent anti-inflammatory and cauterising agent for wounds.

The Chinese have a long history of using Ganoderma lucidum (also known as ling zhi) as a medicinal mushroom, with records dating back to the Chinese materia medica "Shen Nung Ben Cao Jing," written between 206 BC and 8 AD. It was considered a superior tonic for prolonging life, preventing ageing, and boosting qi.

In modern times, several antibiotics have been isolated from mushrooms and microfungi, including penicillin and griseofulvin. Additionally, wild mushroom extracts have been found to enhance the action of standard antibiotics against multi-resistant bacteria. The polysaccharides extracted from certain mushrooms, such as Cordyceps sinensis, have been shown to inhibit the growth of bacteria, indicating potential antibiotic properties.

While the use of mushrooms in medicine has a long history, there is still much to be discovered about their full potential. With tens of thousands of mushroom varieties, only a small fraction has been studied for their potential medicinal properties. As scientific understanding advances, the medical community is recognising the value of mushrooms in modern medicine, particularly in the treatment of cancer and the enhancement of the immune system.

Antibiotics have been isolated from mushrooms

Mushrooms have been used for medicinal purposes throughout history. They are a valuable source of food and income worldwide and are known for their pharmaceutical qualities.

Several antibiotics have been isolated from mushrooms and microfungi, including penicillin and griseofulvin. In addition, researchers have found that polysaccharides extracted from the mushroom Cordyceps sinensis inhibited the growth of the bacteria Bacillus subtilis and Streptococcus epidermidis, while the mushroom P. australis extract restricted the growth of S. epidermidis.

Furthermore, wild mushroom extracts have been shown to potentiate the action of standard antibiotics against multi-resistant bacteria. For example, the combination of wild mushroom extracts and commercial antibiotics such as penicillin and amoxicillin has been found to reduce the therapeutic doses required and contribute to the reduction of resistances.

In addition to their antibacterial properties, mushrooms also exhibit strong antioxidant activity. The intensity of this activity depends on the mushroom species and the solvent used for extraction. This antioxidant activity is attributed to the phenolic and flavonoid content of the mushrooms.

Mushroom extracts can be used to enhance standard antibiotics

Mushrooms have been used for medicinal purposes throughout history. They are a valuable source of food and income worldwide and are known for their pharmaceutical qualities. Certain medicinal mushrooms are beneficial ingredients in dietary supplements.

Several antibiotics have been isolated from various mushrooms and microfungi, including penicillin and griseofulvin. However, there are tens of thousands of mushroom varieties, and only a handful have been studied for their potential antibiotic, antifungal, antiviral, and antiprotozoan properties.

Mushroom extracts have been found to have strong antioxidant and antimicrobial activities in vitro. The intensity of antioxidant activity depends on the mushroom species and the solvent used for extraction. The acetone and methanol extracts of certain mushrooms showed relatively strong antimicrobial activity, with the maximum antimicrobial activity found in the acetone extract of Leccinum carpini against Enterococcus foecalis.

The polysaccharides extracted from the mushroom Cordyceps sinensis inhibited the growth of the bacteria Bacillus subtilis and Streptococcus epidermidis, while the mushroom P. australis extract restricted the growth of S. epidermidis. Wild mushroom extracts have been found to enhance the action of standard antibiotics against multi-resistant bacteria, potentially reducing therapeutic doses and contributing to the reduction of resistances.

Overall, mushroom extracts show promise in enhancing the effectiveness of standard antibiotics, and further research is needed to fully understand their potential in this area.

Mushroom nanoparticles may offer an alternative to traditional antibiotics

Mushrooms have been used for medicinal purposes throughout history. They are a valuable source of food and income worldwide and are known for their pharmaceutical qualities.

In recent times, several antibiotics have been isolated from various mushrooms and microfungi, including penicillin and griseofulvin. However, there are tens of thousands of mushroom varieties, only a handful of which have been studied for their potential antibiotic, antifungal, antiviral, and antiprotozoan properties, as well as other health benefits.

For example, researchers have found that polysaccharides extracted from the mushroom Cordyceps sinensis inhibited the growth of the bacteria Bacillus subtilis and Streptococcus epidermidis, while the mushroom P. australis extract restricted the growth of S. epidermidis.

In another study, scientists from Karpagam University, India, and colleagues from the University of Baghdad, Iraq, and the University of Malaya, Malaysia, added an aqueous extract of mushrooms collected from Iraq to a silver nitrate solution. This solution turned from pale to dark yellow, indicating the formation of silver nanoparticles. Imaging revealed the formation of well-dispersed spherical nanoparticles ranging from 10 to 40 nm in size. These nanoparticles inhibited the growth of five different bacterial strains: Bacillus subtilis, Bacillus cereus, Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. The antibacterial effects depended on the size and dosage of the nanoparticles.

Since commercial antibiotics can have toxic side effects on the liver, kidneys, and nerve cells, mushroom nanoparticles could offer an alternative method for treating bacterial infections. Further research is needed to explore the potential of mushrooms as a source of alternative antibiotics.

Mushrooms are a source of bioactive compounds

Pinecone cap mushrooms, for instance, are a type of fungi that provide the main ingredient in the fight against a worldwide carcinogenic fungus, Aspergillus flavus. The natural fungicide strobilurin, which is one of the most important classes of agricultural fungicides, is derived from mushrooms. Strobilurins inhibit the growth of A. flavus by interrupting its ability to breathe, thereby reducing the amount of aflatoxins that manufacturers must deal with during food processing and packaging.

Additionally, researchers have found that polysaccharides extracted from the mushroom Cordyceps sinensis inhibited the growth of the bacteria Bacillus subtilis and Streptococcus epidermidis, while the mushroom P. australis extract restricted the growth of S. epidermidis. The antioxidant activity of the mushroom extracts was also assessed, with P. australis exhibiting the highest antioxidant activity.

In another study, researchers from Karpagam University in India, along with colleagues from the University of Baghdad, Iraq, and the University of Malaya, Malaysia, added aqueous extract of mushrooms collected from Iraq to a silver nitrate solution. This resulted in the formation of spherical nanoparticles ranging from 10 to 40 nm in size. These nanoparticles inhibited the growth of five different bacterial strains and exhibited antibacterial effects that depended on their size and dosage. As commercial antibiotics can have toxic side effects on the liver, kidneys, and nerve cells, these mushroom-derived nanoparticles offer a potential alternative for treating bacterial infections.

Overall, mushrooms have been used throughout history for medicinal purposes, and they continue to be a valuable source of bioactive compounds with potential antimicrobial, antioxidant, and antibacterial properties.

Frequently asked questions